Brief Description
Azalea Therapeutics is an early-stage biotech startup on a mission to revolutionize genomic medicines. By designing vehicles that enable cell-specific delivery inside the body, the company aims to unlock precision therapeutics for genetic diseases and unleash the promise of cellular-based therapies.
Inventors
Connor Tsuchida, Jennifer Doudna, Jennifer Hamilton
Company Founders
UC Berkeley Professor of Biochemistry, Biophysics and Structural Biology Jennifer Doudna, Jennifer Hamilton (UC Berkeley PhD, Doudna Lab, 2018-2023); Connor Tsuchida (UC Berkeley Postdoc, Doudna Lab, 2023), Abdullah Muhammad Syed (UC Berkeley Postdoc, Doudna Lab, 2020-2023), Stanford University Professor of Bioengineering Michael Fischbach, UCSF Associate Professor of Medicine Justin Eyquem
Timeline
- 2023. Company founded